The Dobos laboratory is focused on descriptive, comparative studies of Mycobacterium tuberculosis strains that are relevant to the development of second-generation vaccines and diagnostic assays. Specifically, the laboratory utilizes mass spectrometry, animal models of tuberculosis, and collaborations with clinical research groups to define macromolecules engaged in host-parasite interactions. This is accomplished through highly collaborative studies within CSU and outside of the University.
Microbiology and Infectious Diseases Biological Research Repository (MID-BRR)
The Dobos laboratory provides crude and purified reagents from M. tuberculosis, M. leprae, and other specialized Mycobacterium species and transfers these reagents to the MID-BRR repository managed by American Type Culture Collection. Products include irradiated cells, subcellular fractions, genomic DNA, crude lipids, purified lipids, lipoglycans, native proteins, and antibodies/antisera.view project
Collaborations with Oregon Health and Sciences University
The Lewinsohn lab focuses on understanding how human CD8+ T cells recognize cell infected with Mycobacterium tuberculosis (Mtb). Areas of interest include defining the repertoire of immunodominant antigens in Mtb, defining the mechanisms by which Mtb-antigens can enter the HLA-I antigen processing pathway, and defining the mechanisms by which innate T cells can recognize cells infected with Mtb.view project
Collaborations with Saint Louis University
Dr. Daniel Hoft treats patients for infectious diseases. His areas of expertise include tuberculosis, parasitology, and vaccination. He is particularly interested in research into vaccine development, especially for Chagas disease, pandemic influenza, and tuberculosis.view project
CDC PHEPRAR contract
The Dobos lab will establish conditions for kill curves for requested genus. After surrogate kill curves are established, ATCC will provide “select agent” genus/species to be tested. These will be irradiated at one dose higher than the minimum dose required to kill the surrogate. The Dobos laboratory provides scientific expertise on the irradiation of select agents and surrogates/near neighbors.
Nontuberculous Mycobacteria Show Differential Infectivity and Use Phospholipids to Antagonize LL-37.
Honda JR, Hess T, Carlson R, Kandasamy P, Nieto Ramirez LM, Norton GJ, Virdi R, Islam MN, Mehaffy C, Hasan NA, Epperson LE, Hesser D, Alper S, Strong M, Flores SC, Voelker DR, Dobos KM, Chan ED.
Am J Respir Cell Mol Biol. 2019 Sep 23. doi: 10.1165/rcmb.2018-0278OC. [Epub ahead of print]
Protein profile of different cellular fractions from Mycobacterium tuberculosis strains after exposure to isoniazid.
Nieto Ramirez LM1,2, Mehaffy C1, Dobos KM1.
Data Brief. 2019 Apr 25;24:103953. doi: 10.1016/j.dib.2019.103953. eCollection 2019 Jun.
Mycobacteria and their sweet proteins: An overview of protein glycosylation and lipoglycosylation in M. tuberculosis.
Mehaffy C, Belisle JT, Dobos KM.
Tuberculosis (Edinb). 2019 Mar;115:1-13. doi: 10.1016/j.tube.2019.01.001. Epub 2019 Jan 14
Deciphering the molecular basis of mycobacteria and lipoglycan recognition by the C-type lectin Dectin-2.
Decout A, Silva-Gomes S, Drocourt D, Blattes E, Rivière M, Prandi J, Larrouy-Maumus G, Caminade AM, Hamasur B, Källenius G1, Kaur D, Dobos KM, Lucas M, Sutcliffe IC, Besra GS, Appelmelk BJ, Gilleron M, Jackson M, Vercellone A, Tiraby G, Nigou J.
Sci Rep. 2018 Nov 15;8(1):16840. doi: 10.1038/s41598-018-35393-5.
Structural determinants in a glucose-containing lipopolysaccharide from Mycobacterium tuberculosis critical for inducing a subset of protective T cells.
De P, McNeil M, Xia M, Boot CM, Hesser DC, Denef K, Rithner C, Sours T, Dobos KM, Hoft D, Chatterjee D.
J Biol Chem. 2018 Jun 22;293(25):9706-9717. doi: 10.1074/jbc.RA118.002582. Epub 2018 May 1.
Lab Principal Investigator (PI)
Director, Research Integrity & Compliance Review Office (RICRO)
Research Scientist/Scholar II
Laboratory Manager, BEI Project Manager
Research Associate III
Research Associate II
Research Assistant I
Graduate Research Assistant
High School Student Researcher
Dobos lab retreat at the Estes Park ropes course (2019).
news and updates
Top Colorado State University researchers mobilized their disciplines over the course of the past year to address challenges raised by the global coronavirus pandemic.
The Dobos lab is making hand sanitizer to help with the shortage.
The Dobos lab helped to make hand sanitizer for various entities across CSU.
Research Innovation Center (RIC) D139